HKND
Humankind US Stock ETF
HKND tracks an index that selects and weights US stocks, of any capitalization, based on socially responsible investment criteria.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 141.5 M
ASSETS UNDER MGMT
11 bp
EXPENSES
Fund Basics
| Inception date | Feb 24, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ZIMMER BIOME-CVR | 0.0 % |
| BLUEPRINT MED CVR | 0.0 % |
| ABIOMED INC -CVR | 0.0 % |
| OMNIAB -EARNOUT | 0.0 % |
| INHIBRX INC CVR | 0.0 % |
| BRISTOL-MYER-CVR | 0.0 % |
| ALBIREO PHARMA I -CVR | 0.0 % |
| NOVARTIS AG-CVR | 0.0 % |
Constituent Breakdown
| Number of holdings | 9 |
| Herfindahl-Hirschman Index | 0 |
| Wgt avg mkt cap (mns) | $0 |
| Large cap (>$10bn) | 0.0% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 0.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
Historical Performance
Standardized Performance (as of 12/31/2025)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 11.1% | 11.1% | 9.9% | 10.1% | -- | -- | -- | 7.1% |
| Dividend Yield | 2.0% | 2.0% | 1.9% | 2.0% | -- | -- | -- | 1.9% |
| Total Returns | 13.1% | 13.1% | 11.9% | 12.0% | -- | -- | -- | 9.0% | Ann. Volatility | 16.0% | 16.0% | 13.4% | 12.8% | -- | -- | -- | 14.4% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.60 | 45% |
| MSCI EAFE | 0.71 | 55% |
| MSCI Emg Mkts | 0.39 | 30% |
Liquidity Measures
| Avg. volume (000) | 0 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.57% |
Technical Indicators
| 30d moving avg. (EMA) | $35.08 |
| Relative strength (RSI) | 56 |
| MACD/Signal | 0.12/0.11 |
| Bollinger Bands (Upper/Lower) | $35.72/$34.57 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. HKND |
Expenses vs. HKND |
ALTAR Score™ vs. HKND |
|---|
Risk and Returns: HKND vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| Sales per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Book value per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | ||||
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 9/10/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.4%
ALTAR SCORE™
71st
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,407 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.0%. HKND's ALTAR Score™ is approximately 0.5 standard
deviations above the category average. This places HKND in the 71st percentile
among funds in the category.
Sell-Side Consensus
$
PRICE TARGET
-100.0%
UPSIDE